NVO vs NVS: Stock Comparison

Novo Nordisk A/S (NVO) has a market cap of $169.61B and Novartis AG (NVS) has a market cap of $297.76B. The trailing P/E is 1.46 for NVO and 23.59 for NVS. The 1-year total return is -25.95% for NVO and +23.82% for NVS.

See NVOSee NVS

Key metrics

MetricNVONVS
Price$38.45$156.66
Market cap$169.61B$297.76B
P/E1.4623.59
Revenue growth+6.43%+5.97%
Operating margin+43.13%+29.86%
Dividend yield4.67%3.03%
1-year total return-25.95%+23.82%
3-year total return-56.45%+84.30%
5-year total return-20.81%+130.00%

Performance

Total return (%)

0.0%+100%+200%Oct 2021Jun 2023Feb 2025Oct 2026

Date

NVONVS

Total return from Oct 8, 2021 to Oct 27, 2026, rebased to the first date.

Which is better for...

  • Income. NVO yields more, at 4.67% versus 3.03% for NVS.
  • The past year. NVS returned more, at +23.82% versus -25.95% for NVO.
  • Valuation. NVO has the lower trailing P/E, at 1.46 versus 23.59 for NVS.
  • Growth. NVO has faster revenue growth, at +6.43% versus +5.97% for NVS.
  • The past five years. NVS returned more, at +130.00% versus -20.81% for NVO.

These lines restate the figures above. They are not a recommendation.

Frequently asked questions

What is the market cap of NVO vs NVS?

Novo Nordisk A/S (NVO) has a market cap of $169.61B. Novartis AG (NVS) has a market cap of $297.76B.

How did NVO and NVS perform over the past year?

The 1-year total return is -25.95% for NVO and +23.82% for NVS.

Which has the higher dividend yield, NVO or NVS?

NVO's dividend yield is 4.67%. NVS's dividend yield is 3.03%.

What is the 5-year total return of NVO vs NVS?

The 5-year total return is -20.81% for NVO and +130.00% for NVS.

Is this comparison investment advice?

No. This page reports published figures for NVO and NVS. It is not a recommendation.

Compare other stocks